I-MAB Biopharma Overview

Life ScienceCompany

Was I-MAB Biopharma formerly PE-backed?

Yes. I-MAB Biopharma was formerly owned by 1 private investor.

Where is I-MAB Biopharma headquartered?

I-MAB Biopharma is headquartered in Rockville, Maryland.

What is I-MAB Biopharma’s revenue?

I-MAB Biopharma disclosed revenue of 1M USD for 2023 and 14M USD for 2021.

How many employees does I-MAB Biopharma have?

I-MAB Biopharma has 32 employees.

What sector is I-MAB Biopharma in?

I-MAB Biopharma is a life science company.

When was I-MAB Biopharma founded?

I-MAB Biopharma was founded in 2014.

I-MAB Biopharma

I-MAB Biopharma Co. Ltd.

2440 Research Blvd., Suite 400,
Rockville, Maryland 20850
United States,
(240) 745-6330
www.i-mabbiopharma.com

I-MAB Biopharma is a global biotech company exclusively focused on developing innovative biologics of first-in-class or best-in-class potential in the therapeutic areas of immuno-oncology and autoimmune diseases. I-MAB Biopharma was founded in 2014 and is based in Rockville, Maryland.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # - - - - - 1 1
vol $3M $3M
Sell (0.0/yr) # - - - - - - 0
  1

Top M&A Advisors

Legal Deals
Sidley
1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.